Peter Sands
Peter Sands is the executive director of the Global Fund for HIV, TB and Malaria, where he advocates for innovative solutions to combat global health issues. A former investment banker, Sands emphasizes the importance of economic arguments in securing funding for health initiatives, particularly in the fight against HIV. He has been instrumental in promoting the roll-out of lenacapavir, a groundbreaking anti-HIV jab, demonstrating his commitment to improving health outcomes in low-income countries.
Not in the pool (under ¢1).
Recent news mentions
Peter Sands, executive director of the Global Fund, noted the breakthrough in the introduction of lenacapavir in low- and middle-income countries.
Five big global health wins in 2025 that will save millions of lives | Global health
United Kingdom· 2025-12-22
Peter Sands, executive director of the Global Fund, said 1,000 doses have been delivered.
US delivers HIV prevention drug to two African states
Kenya· 2025-11-18
Peter Sands, executive director of the Global Fund, stated that lenacapavir can fundamentally change the trajectory of the HIV epidemic.
WHO recommends twice-a-year HIV prevention shot
Ghana· 2025-07-14
Peter Sands, executive director of the Global Fund, stated that lenacapavir can fundamentally change the trajectory of the HIV epidemic.
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
United States· 2025-07-14Peter Sands, executive director of the Global Fund, discussed the availability of a new tool to prevent HIV infection.
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Guyana· 2025-07-10Peter Sands, director of the Global Fund, described Lenacapavir as a turning point for HIV and Aids.
Aids-Krise: US-Kürzungen gefährden Millionen Leben weltweit - Gesundheit
Germany· 2025-07-10
Peter Sands, executive director of the Global Fund, acknowledged that achieving health self-sufficiency is a gradual process.
La cumbre de Sevilla de la ONU pide a los países reforzar su autonomía sanitaria | Planeta Futuro
Spain· 2025-07-02
Peter Sands, the executive director of the Global Fund, stated that they are not backing off the ambition to deliver Lenacapivir to two million people if they can.
Elon Musk says Doge didn’t cut HIV programs. But it threw a ‘miracle drug’ into chaos | USAIDUnited Kingdom· 2025-05-24
Peter Sands is the executive director of the Global Fund and confirmed plans to proceed with the lenacapavir deal.
The six-monthly anti-HIV jab could end Aids in SA by 2032 – The Mail & Guardian
South Africa· 2025-04-09
Peter Sands, the Global Fund executive director, emphasizes the importance of lenacapavir in the fight against HIV.
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar – The Mail & GuardianSouth Africa· 2025-03-05
